...
首页> 外文期刊>Journal of Clinical Microbiology >Multiplex PCR Assay for Unequivocal Differentiation of Actinobacillus pleuropneumoniae Serovars 1 to 3, 5 to 8, 10, and 12
【24h】

Multiplex PCR Assay for Unequivocal Differentiation of Actinobacillus pleuropneumoniae Serovars 1 to 3, 5 to 8, 10, and 12

机译:胸膜肺炎放线杆菌血清1至3、5至8、10和12的明确区分的多重PCR分析

获取原文
           

摘要

An improved multiplex PCR, using redesigned primers targeting the serovar 3 capsule locus, which differentiates serovars 3, 6, and 8 Actinobacillus pleuropneumoniae isolates, is described. The new primers eliminate an aberrant serovar 3-indicative amplicon found in some serovar 6 clinical isolates. Furthermore, we have developed a new multiplex PCR for the detection of serovars 1 to 3, 5 to 8, 10, and 12 along with apxIV, thus extending the utility of this diagnostic PCR to cover a broader range of isolates.
机译:描述了一种改进的多重PCR,该方法使用重新设计的针对血清型3囊基因座的引物进行了区分,这些引物区分了血清型3、6和8的胸膜肺炎放线杆菌分离株。新的引物消除了在某些血清型6临床分离物中发现的异常的血清型3指示性扩增子。此外,我们开发了一种新的多重PCR,可与 apxIV 一起检测血清1至3、5至8、10和12,从而扩展了该诊断PCR的应用范围分离株。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号